# Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES)

> **NCT04568707** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 238 (actual)

## Conditions studied

- Covid19
- Neurologic Manifestations
- Psychiatric Manifestations

## Interventions

- **OTHER:** blood sample

## Key facts

- **NCT ID:** NCT04568707
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-23
- **Primary completion:** 2022-12-14
- **Final completion:** 2022-12-14
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2024-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04568707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04568707, "Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04568707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*